dexamethasone intraocular suspension
Showing 1 - 25 of 4,839
DEXYCU 9% Retrospective Study 001
Completed
- Cataract
- DEXYCU (dexamethasone intraocular suspension) 9%.
-
Dothan, Alabama
- +21 more
May 24, 2021
Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,
Not yet recruiting
- Pseudophakic Bullous Keratopathy
- +2 more
- Fluorometholone 0.1% Oph Susp
- +2 more
- (no location specified)
Feb 7, 2023
Dry Eye Syndromes Trial in Sycamore (dexamethasone intraocular suspension, 9%, Prednisolone Acetate 1% Oph Susp)
Completed
- Dry Eye Syndromes
- dexamethasone intraocular suspension, 9%
- Prednisolone Acetate 1% Oph Susp
-
Sycamore, IllinoisHauser Ross Surgical Center
Jan 31, 2021
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative Trial (OCS-01)
Not yet recruiting
- Uveitis Related Cystoid Macular Edema
- Cystoid Macular Edema, Postoperative
- (no location specified)
Nov 1, 2022
Cataract Trial in Dayton (Dextenza 0.4Mg Ophthalmic Insert)
Completed
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
-
Dayton, OhioIworks Laser & Vision Center
Dec 22, 2022
Cataract Surgery, Glaucoma Surgery Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED
Withdrawn
- Cataract Surgery
- Glaucoma Surgery
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
- (no location specified)
Nov 16, 2021
Inflammation, Pain, Postoperative, Trismus Trial in Granada (Dexamethasone 4 Mg/mL Injectable Solution, MethylPREDNISolone 40
Recruiting
- Inflammation
- +2 more
- Dexamethasone 4 Mg/mL Injectable Solution
- MethylPREDNISolone 40 Mg/mL Injectable Suspension
-
Granada, SpainUnai Fernández Martín
Feb 28, 2023
Cataract Trial (Dexamethasone 0.4 MG [Dextenza])
Not yet recruiting
- Cataract
- Dexamethasone 0.4 MG [Dextenza]
- (no location specified)
Nov 22, 2021
Cataract Trial (Dexamethasone 0.4 MG [Dextenza])
Not yet recruiting
- Cataract
- Dexamethasone 0.4 MG [Dextenza]
- (no location specified)
Oct 27, 2021
Intraocular Pressure, Corneal Opacity Trial in Murray (Loteprednol Etabonate 0.5% Oph Gel, Prednisolone Acetate 1% Oph Susp)
Completed
- Intraocular Pressure
- Corneal Opacity
- Loteprednol Etabonate 0.5% Oph Gel
- Prednisolone Acetate 1% Oph Susp
-
Murray, UtahMoran Eye Center - Midvalley Location
May 4, 2021
Cataract Surgery Trial in Kansas City (Omidria, Dextenza (dexamethasone ophthalmic insert) 0.4mg, Dexycu, 9% Intraocular
Unknown status
- Cataract Surgery
- Omidria
- +3 more
-
Kansas City, MissouriSilverstein Eye Centers
Mar 18, 2020
Inflammation Eye, Pain, Postoperative, Cataract Trial in United States (Dexamethasone Ophthalmic Suspension, Vehicle of OCS-01)
Not yet recruiting
- Inflammation Eye
- +2 more
- Dexamethasone Ophthalmic Suspension
- Vehicle of OCS-01
-
Inglewood, California
- +11 more
Nov 7, 2023
Acute Adenoviral Conjunctivitis Trial in United States (FST-100 Ophthalmic Suspension, Placebo)
Terminated
- Acute Adenoviral Conjunctivitis
- FST-100 Ophthalmic Suspension
- Placebo
-
Torrance, California
- +12 more
Aug 22, 2021
Inflammation Corneal, Pain, Postoperative Trial in United States (OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic
Completed
- Inflammation Corneal
- Pain, Postoperative
- OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL
- Placebo
-
Petaluma, California
- +3 more
Feb 17, 2022
Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate
Completed
- Bilateral Conjunctivitis (Disorder)
- Dexamethasone ophthalmic insert 0.4Mg
- +2 more
-
Pompano Beach, FloridaClinical Research Center of Florida
Apr 6, 2022
Acute Otitis Externa Trial in Pago Pago (FST201 (dexamethasone 0.1% with povidone-iodine 1%), Ciprodex (Ciprofloxacin 0.3%;
Completed
- Acute Otitis Externa
- FST201 (dexamethasone 0.1% with povidone-iodine 1%)
- Ciprodex (Ciprofloxacin 0.3%; dexamethasone 0.1% )
-
Pago Pago, American SamoaLBJ Tropical Medical Center, Department of Otolaryngology
Jun 9, 2021
Cataract Trial in Vineland (Dexamethasone, Prednisolone Acetate 1% Oph Susp)
Recruiting
- Cataract
- Dexamethasone
- Prednisolone Acetate 1% Oph Susp
-
Vineland, New JerseyEye Associates of Vineland
Mar 17, 2021
Chronic Suppurative Otitis Media Trial (ciprofloxacin and dexamethasone suspension)
Not yet recruiting
- Chronic Suppurative Otitis Media
- ciprofloxacin and dexamethasone suspension
- (no location specified)
Nov 12, 2021
Acute Otitis Externa Trial in United States (FST-201 (dexamethasone 0.1%) Otic Suspension, ciprofloxacin 0.3%, dexamethasone
Terminated
- Acute Otitis Externa
- FST-201 (dexamethasone 0.1%) Otic Suspension
- ciprofloxacin 0.3%, dexamethasone 0.1%
-
Boynton Beach, Florida
- +5 more
May 24, 2021
Dry Eye Disease, Cataract Surgery, Ocular Surface Disease Trial (Dextenza 0.4Mg Ophthalmic Insert)
Not yet recruiting
- Dry Eye Disease
- +2 more
- Dextenza 0.4Mg Ophthalmic Insert
- (no location specified)
Dec 10, 2020
Acute Fungal Otitis Externa Trial in United States (FST-201 (dexamethasone 0.1%) Otic Suspension, Vehicle)
Terminated
- Acute Fungal Otitis Externa
- FST-201 (dexamethasone 0.1%) Otic Suspension
- Vehicle
-
Boynton Beach, Florida
- +5 more
May 24, 2021
Steroid Ophthalmic Insert Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Fluorometholone)
Not yet recruiting
- Steroid Ophthalmic Insert
- Dextenza 0.4Mg Ophthalmic Insert
- Topical Fluorometholone
- (no location specified)
Oct 17, 2022
Acute Otitis Externa Trial in Puerto Rico, United States (Ciprodex®, EXL CDOS (Ciprofloxacin 0.3% and Dexamethasone 0.1%)
Completed
- Acute Otitis Externa
- Ciprodex®
- EXL CDOS (Ciprofloxacin 0.3% and Dexamethasone 0.1%) Sterile Otic Suspension
-
Birmingham, Alabama
- +47 more
May 27, 2021